Public Employees Retirement System of Ohio lessened its stake in shares of Innospec Inc. (NASDAQ:IOSP) by 2.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 44,233 shares of the specialty chemicals company’s stock after selling 1,024 shares during the period. Public Employees Retirement System of Ohio’s holdings in Innospec were worth $3,943,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. California State Teachers Retirement System raised its stake in shares of Innospec by 1.3% in the third quarter. California State Teachers Retirement System now owns 37,882 shares of the specialty chemicals company’s stock worth $3,377,000 after buying an additional 470 shares during the period. Covington Capital Management purchased a new position in Innospec during the third quarter valued at approximately $25,000. Virtu Financial LLC purchased a new position in Innospec during the third quarter valued at approximately $204,000. Voya Investment Management LLC boosted its position in shares of Innospec by 26.0% in the third quarter. Voya Investment Management LLC now owns 19,273 shares of the specialty chemicals company’s stock worth $1,718,000 after purchasing an additional 3,980 shares during the period. Finally, Mason Street Advisors LLC boosted its position in shares of Innospec by 1.8% in the third quarter. Mason Street Advisors LLC now owns 8,314 shares of the specialty chemicals company’s stock worth $741,000 after purchasing an additional 143 shares during the period. Institutional investors and hedge funds own 92.82% of the company’s stock.

NASDAQ:IOSP opened at $100.01 on Friday. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.18. Innospec Inc. has a 12-month low of $53.07 and a 12-month high of $107.10. The stock has a 50-day moving average price of $95.23 and a 200 day moving average price of $89.68. The stock has a market capitalization of $2.41 billion, a P/E ratio of 18.26 and a beta of 1.27.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.40 EPS for the quarter, topping the Zacks’ consensus estimate of $1.25 by $0.15. Innospec had a return on equity of 15.52% and a net margin of 6.69%. The company had revenue of $371.90 million for the quarter, compared to analysts’ expectations of $367.65 million. During the same period in the previous year, the firm earned $1.20 EPS. The firm’s revenue was up 2.4% compared to the same quarter last year.

The business also recently disclosed a Semi-Annual dividend, which was paid on Wednesday, November 27th. Stockholders of record on Tuesday, November 19th were given a dividend of $0.52 per share. The ex-dividend date was Monday, November 18th. This is a boost from Innospec’s previous Semi-Annual dividend of $0.50.

In related news, VP Philip John Boon sold 23,819 shares of the business’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $96.19, for a total value of $2,291,149.61. Following the sale, the vice president now directly owns 42,408 shares in the company, valued at $4,079,225.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Brian Watt sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $96.71, for a total value of $290,130.00. Following the completion of the sale, the vice president now owns 25,321 shares in the company, valued at $2,448,793.91. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,819 shares of company stock worth $3,278,030. Company insiders own 1.62% of the company’s stock.

Several analysts have recently commented on IOSP shares. BidaskClub downgraded shares of Innospec from a “buy” rating to a “hold” rating in a research report on Thursday, September 26th. CL King started coverage on shares of Innospec in a report on Wednesday, September 4th. They issued a “buy” rating and a $95.00 target price for the company. Finally, ValuEngine raised shares of Innospec from a “strong sell” rating to a “sell” rating in a report on Friday, November 8th.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels.

Read More: What is the Nikkei 225 index?    

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.